Generalized Anxiety Disorder (GAD) is a common and disabling disorder characterised by excessive worry (apprehensive expectation), anxiety and somatic symptoms. Unfortunately, being that the diagnosis of GAD is poorly recognized, general practitioners and mental healthcare professionals are not exactly aware of the presenting symptoms. The...
-
2014 (v1)PublicationUploaded on: May 13, 2023
-
2013 (v1)Publication
No description
Uploaded on: May 12, 2023 -
2015 (v1)Publication
The main focus of this narrative review is to present and discuss the most relevant clinical data about the pharmacological therapy for alcohol use disorders. By using PubMed we conducted a review of the clinical literature on drugs related to alcohol use disorders. All data are presented following the three phases of treatment: a) from...
Uploaded on: May 12, 2023 -
2014 (v1)Publication
Generalized Anxiety Disorder may be seen as a gateway condition from normalcy to pathology with blurred boundaries towards several concurrent disorders. This anxiety illness is responsible for psychological suffering and personal dysfunction in a considerable proportion of individuals in the general population. Since its original definition in...
Uploaded on: May 12, 2023 -
2012 (v1)Publication
Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of...
Uploaded on: May 13, 2023 -
2012 (v1)Publication
Introduction: Alcohol dependence represents a severe pathological disorder associated with a significant rate of morbidity and mortality. To date, limited pharmacological agents exist to treat this disorder, and there is a growing interest for new therapies. In this context, pregabalin represents a promising strategy. Pregabalin, like...
Uploaded on: May 12, 2023 -
2015 (v1)Publication
Background The goal of the current meta-analysis was to review and examine in detail the features of cognitive performance in psychotic (MDDP) versus non-psychotic (MDD) major depressive disorder. Methods An electronic literature search was performed to find studies comparing cognitive performance in MDDP versus MDD. A meta-analysis of broad...
Uploaded on: May 13, 2023 -
2013 (v1)Publication
Background: Migraine is a primary headache disorder characterized by recurrent episodes of headache associated with gastrointestinal, neurologic, and autonomic symptoms. Some evidence in literature suggests that the melatonergic system possibly plays an important role in the pathogenesis of migraine. Few studies have been performed on the use...
Uploaded on: May 12, 2023 -
2015 (v1)Publication
To date, a limited number of pharmacological agents exist to treat alcohol use disorders (AUDs), and there is growing interest in new therapeutic tools. In this framework, topiramate may represent a useful treatment option, although its use is not yet approved for AUDs. The main focus of this review is to discuss all the existing data...
Uploaded on: May 12, 2023 -
2018 (v1)Publication
Objective Despite several studies that have highlighted the harmful effects of alcohol consumption on cognitive functions it remains unclear whether certain brain areas are more sensitive than others are or whether alcohol causes widespread cognitive deficit. Moreover, the role of continued abstinence has yet to be clarified regarding the...
Uploaded on: May 12, 2023 -
2015 (v1)Publication
Pseudohypoparathyroidism type 1A and its association with bipolar disorder (BD) have never been reported so far. We report a new case with both clinical entities and discuss the potential pathophysiological mechanisms of this association (protein kinase A hypoactivation, parathyroid hormone, hypocalcemia, protein kinase C activation, vitamin D...
Uploaded on: May 12, 2023